Skip to content

There are over 45,000 medical cannabis patients in the UK. Find out if you qualify

  • Patient Guide Coming Soon
Medical Cannabis Patients Hub
  • About
  • contact
  • Articles
  • Strains
  • Cannabinoids
  • Terpenes
Menu
  • About
  • contact
  • Articles
  • Strains
  • Cannabinoids
  • Terpenes

CBGA

CBGA
Chemical Structure: Cannabigerolic Acid (CBGA) – C₂₂H₃₂O₄
Therapeutic Uses: Potential uses include anti-inflammatory, neuroprotective, and anti-cancer properties; may help in treating metabolic disorders and cardiovascular diseases.
Legal Status: Legal in the UK when derived from hemp with less than 0.2% THC.
Cannabigerolic acid (CBGA) is critical in the cannabis plant’s metabolic pathway, serving as a precursor to major cannabinoids like THC and CBD. Though research is in early stages, studies suggest CBGA could play a vital role in medical treatments, potentially aiding in cardiovascular, metabolic, and cancer-related therapies. Its legal status in the UK permits use in certain forms, fostering further research and use in therapeutic contexts.

Detailed Cannabinoid Information

Introduction – About Cannabigerolic Acid (CBGA)

CBGA stands for cannabigerolic acid, a foundational compound in the biosynthesis of cannabis cannabinoids. Cannabigerolic acid (CBGA) is often called the “granddaddy” of cannabinoids because it serves as a precursor to several other major cannabinoids in the cannabis plant, including THCA, CBDA, and CBCA.

Chemical Structure and Interaction

CBGA interacts with the endocannabinoid system but is primarily significant for its role in the synthesis of other cannabinoids. It is converted into THC, CBD, and CBC through enzymatic processes that occur as the cannabis plant matures.

History and Discovery

CBGA was first isolated over 50 years ago by Israeli researchers. Its role as a precursor to other cannabinoids was further clarified by Japanese researchers who determined that CBGA converts into other acids that directly contribute to the formation of active cannabinoids.

Legal and Regulatory Status in the UK

Like other cannabinoids, the legal status of CBGA in the UK is tied to its source and THC content. Products containing CBGA derived from hemp (containing less than 0.2% THC) are legal.

Methods of Consumption

CBGA can be consumed in its natural form directly from young cannabis plants. More commonly, it is present in full-spectrum CBD oils which retain a spectrum of cannabinoids.

Pharmacokinetics

The body processes CBGA as it converts into other cannabinoids. The pharmacokinetics of CBGA itself are not well-studied due to its rapid conversion into either THCA or CBDA in the plant.

Clinical Applications in the UK

Research into CBGA’s direct clinical applications is limited but growing. Early studies suggest potential benefits in treating conditions such as cardiovascular disease, metabolic disorders, and colon cancer, though more research is needed.

Adverse Effects

As with many cannabinoids, the safety profile of CBGA is not well-documented, but it is considered to have a low risk of adverse effects. Ongoing studies are required to fully understand its pharmacological impact.

  • Our resources are here to help!

New Patient?

Check Your Eligibility →

Want to Know About Cannabis Clinics?

  • Coming Soon

Is Medical Cannabis for You?

  • Coming Soon

© MCPH UK | Green Creative 2024. All right reserved.

  • Facebook Group
  • Twitter